PubMed COVID-19 Clinical Care
41101 - 41110 of 44979 results found
There is No Place Like Home for the Holidays: Who Travels in the Midst of a Deadly Pandemic?
Description
The 2020 year-end holidays were a time of much apprehension regarding COVID-19, with U.S. health officials concerned that travel would result in a post-holiday surge of the disease. As such, much effort was expended encouraging people to forego their
Decolonising vaccine production: Unpacking Ghanaians' support for made-in-Africa vaccines
Description
Localisation of vaccine production is essential worldwide, but it is particularly crucial for Africa. This continent is more vulnerable to disease burdens and also lags behind other continents regarding access to vaccines. Moreover, many people in
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Description
Vaccines play a critical role in combating the COVID-19 pandemic. Future control of the pandemic requires improved vaccines with high efficacy against newly emerging SARS-CoV-2 variants and the ability to reduce virus transmission. Here we compare
The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer
Description
CONCLUSIONS: Although the impact of the COVID-19 pandemic on perioperative chemotherapy on whole groups of patients was not evident when comparing periods before and after the pandemic, the impact is becoming prominent in parallel with increasing
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Description
CONCLUSIONS: In these international guidelines, ERS, ESICM, ESCMID and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment and antibiotic therapy for sCAP, following the GRADE approach. Furthermore
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Description
The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in humans, but the emergence of highly infectious variants necessitated additional doses and the development of new variant-derived vaccines^(1-4). SARS-CoV-2 booster
Cross-regional analysis of the association between human mobility and COVID-19 infection in Southeast Asia during the transitional period of "living with COVID-19"
Description
CONCLUSIONS: The loosening interventions in response to COVID-19 in SEA countries during the second half of 2021 led to diverse changes in human mobility over time, which may result in the COVID-19 infection dynamics. This study investigated the
